Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Philipp Burow"'
Autor:
Armin Scheffler, Pauline Wenzel, Merle Bendig, Astrid Gendolla, Jale Basten, Christoph Kleinschnitz, Michael Nsaka, Diana Lindner, Steffen Naegel, Philipp Burow, Robert Fleischmann, Dagny Holle
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Eptinezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP mAb) and is used for migraine prophylaxis. Efficacy data are mainly from clinical trials, real-world data are hardly available yet. Reimbursem
Externí odkaz:
https://doaj.org/article/5f1fd9fe00a7444eb098894b6f3673ca
Autor:
Ana Sofia Oliveira Gonçalves, Inga Laumeier, Maxi Dana Hofacker, Bianca Raffaelli, Philipp Burow, Markus A. Dahlem, Simon Heintz, Tim Patrick Jürgens, Steffen Naegel, Florian Rimmele, Simon Scholler, Tobias Kurth, Uwe Reuter, Lars Neeb
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundDigitalization and electronic health (eHealth) offer new treatment approaches for patients with migraine. Current smartphone applications (apps) for migraine patients include a wide spectrum of functions ranging from digital headache diarie
Externí odkaz:
https://doaj.org/article/9e8dd88129a04c15902f1ecdc5bcfd0a
Autor:
Philipp Burow, Marc Haselier, Steffen Naegel, Leila Motlagh Scholle, Charly Gaul, Torsten Kraya
Publikováno v:
Cells, Vol 10, Iss 9, p 2471 (2021)
Mitochondrial processes may play a role in the pathophysiology of migraine. Serum levels of two biomarkers, Fibroblast-growth-factor 21 (FGF-21) and Growth-differentiation-factor 15 (GDF-15), are typically elevated in patients with mitochondrial diso
Externí odkaz:
https://doaj.org/article/2904a984a9e74dc9b07c998883916bac
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Introduction: “Headache attributed to ingestion or inhalation of a cold stimulus” (HICS) is one of the most common primary headache disorders. Little is known about the pathophysiology of HICS and other headache disorders. The aim of this study w
Externí odkaz:
https://doaj.org/article/38392bba12fd4763b5df3f9b23f2ea82
Publikováno v:
Acta Neurologica Belgica. 123:441-450
Background Numerous but inconclusive findings have sparked an ongoing debate about whether the arteries of migraine patients undergo vascular alterations. The outlet angle of the superior cerebellar artery (SUCA) and the lateral displacement of basil
Publikováno v:
Acta Neurologica Belgica. 122:931-937
Erenumab is a monoclonal antibody, targeted against the calcitonin gene-related peptide (CGRP) receptor. Clinical studies have demonstrated prophylactic efficacy in both episodic (EM) and chronic migraine (CM). The aim of the present study is to eval
Publikováno v:
Acta Neurologica Belgica
Headache is frequent in patients with mitochondrial disorders. Previous studies point to a higher prevalence of headache in these patients than in the general population. As mitochondrial disorders often present a variety of other symptoms, the quest
Autor:
Simon Heintz, Philipp Burow, Torsten Kraya, Dietrich Stoevesandt, Stephan Zierz, Annemarie Thaele, Dagny Holle, Steffen Naegel
Publikováno v:
Headache: The Journal of Head and Face Pain. 61:694-696
Autor:
Charly Gaul, Marc Haselier, Leila Motlagh Scholle, Steffen Naegel, Philipp Burow, Torsten Kraya
Publikováno v:
Cells
Cells, Vol 10, Iss 2471, p 2471 (2021)
Volume 10
Issue 9
Cells, Vol 10, Iss 2471, p 2471 (2021)
Volume 10
Issue 9
Mitochondrial processes may play a role in the pathophysiology of migraine. Serum levels of two biomarkers, Fibroblast-growth-factor 21 (FGF-21) and Growth-differentiation-factor 15 (GDF-15), are typically elevated in patients with mitochondrial diso